NURC
NOTICE OF UPDATED REGISTRATION CONFIRMATION EMAILED
24/01/2023
Voltar para busca
Dado oficial do USPTO
COMMAND-LINE ACCESS TO LIFE
Sabia que essa marca já está registrada no Estados Unidos?
Antes de investir em nome, identidade e divulgação, valide risco de colisão e estratégia de registro para não perder tempo nem budget.
Active USPTO registrationTipo: VerbalEscritório: Estados Unidos
Snapshot rápido
COMMAND-LINE ACCESS TO LIFE
ST13
US500000088373158Classe
1, 5, 9, 29, 42
Pedido
88373158
Registro
6557696
Diagnóstico de risco e oportunidade
Leitura executiva para decisão de naming, protocolo e monitoramento.
Situação USPTO
Active USPTO registration
Tipo de processo
Pedido e registro
Eventos registrados
43
Atualização mais recente
28/04/2023
Tipo de marca
Verbal
Classes Nice
1, 5, 9, 29, 42
Data de depósito
05/04/2019
Data de registro
16/11/2021
Data de expiração
-
Dados completos do processo
Campos estruturados da autoridade responsável e do histórico oficial.
Data da situação
16/11/2021
Última transação
28/04/2023
Escritório responsável
United States Patent and Trademark Office
Código da situação
700
Cadastro oficial
Principal Register
Fundamento do pedido
Intent to use
Código do desenho
4
Tipo de titular
99
Localização do titular
Cambridge, GB
Examinador
CALLOWAY,CHRISTINA DENISE
Unidade examinadora
N40
Localização atual
TMO LAW OFFICE 122
Titulares e representantes
Titulares
Elpis Biomed Ltd
Representantes
Katrina G. Hull Markery Law LLC
Classificação técnica
Classes Nice
Classe 1Classe 5Classe 9Classe 29Classe 42
Códigos Vienna
Sem códigos Vienna disponíveis.
Produtos e serviços
Classe 1
Stem cells for research purposes; Stem cells for scientific purposes; Stem cells other than for medical or veterinary purposes; Provision of skeletal myocytes for research purposes; Provision of cortical neurons for research purposes; Biological human tissue for research and scientific purposes; Biological tissue cultures other than for medical or veterinary purposes; Cultures of cell media; Chemical reagents for use in biotechnologyother than for medical or veterinary use; Nutritive agents for processing living cells; Semi-processed natural proteins for manufacturing food; Proteins for use in the manufacture of food products; Proteins for use in recombinant DNA technology
Classe 5
Pharmaceuticals in the nature of cell therapeutics; Genetically and otherwise modified cells for medical or clinical use; Cells which are propagatedcultivated and expanded in bioreactors for medical or clinical use; Cells for the purpose of tissue regeneration for medical or clinical use; Living cells for medical use; Cells for medical use; Diagnostic preparations for medical and veterinary purposes; Cell preparations for drug screening; Cell preparations for genetic testingscreening; Stem cells for medical purposes; Stem cells for veterinary purposes; Cell growth media for growing cellstissue culture mediacytokinesantibodiesreagents for medicalmedical research and diagnostic or clinical use; Tissue culture mediagrowth factors in the nature of cell growthcell growth medianutritional supplements for in vitro culturingdevelopmentmaintenanceexpansionassay or manipulation of cells; Cell separation reagents for medical or clinical use; Dietary supplements; Protein supplements; nutrition supplements
Classe 9
Downloadable computer software and computer hardware for the separation of biological and non-biological materials; Bioreactors for biomanufacturing; Bioreactors for research use; Bioreactor for cell culturing; Bioreactors for laboratory use; Downloadable and recorded computer-aided manufacturing software for the separation of biological and non-biological materials; Smart manufacturing system controls for laboratory robots and laboratory automation equipment featuring downloadable software incorporating algorithms to control laboratory robots and laboratory automation equipment; Electronic control units for laboratory robots and laboratory automation equipment featuring downloadable software incorporating algorithms to control laboratory robots and laboratory automation equipment; magnetic cell separation equipmentapparatus for the separation of cell populations for medical or clinical use
Classe 29
Meat; Meat substitutes; Tissue engineered meat; Synthetic meat; Cultured meat; Laboratory-grown meat; Fishnot live
Classe 42
Biotechnology research; Biotechnology testing; Stem cell research; Synthetic biology servicesbiological research; Stem cell biology servicesbiological research; Scientific services relating to the isolation and cultivation of human tissues and cells; Research and development in the field of microorganisms and cells; Research and development in relation to genetic testingscreening; Research and development in relation to drug screening; Cell separation technology services; Cell separation research services; Consultancy relating to biotechnology; Scientific and research consultancy relating to drug screening; Scientific and research consultancy relating to genetic screening; Scientific and research consultancy relating to cell therapy; Laboratory research in the field of drug discoverycell therapystem cellsmicroorganismshuman tissuessynthetic biology and biomanufacturing; Research on food; Research and development in the field of animal cells cultivated within bioreactors; Research in the reduction of carbon emissions; Providing temporary use of non-downloadablecloud-basedcomputer-aided manufacturing software for the separation of biological and non-biological materials
Publicações
Histórico de despachos e eventos da marca no USPTO.
43 publicações encontradas
COC.
CORRECTION UNDER SECTION 7 - PROCESSED
17/12/2022
EROP
TEAS RESPONSE TO OFFICE ACTION-POST REG RECEIVED
14/12/2022
PRAM
POST REGISTRATION ACTION MAILED - SEC. 7
30/06/2022
APRE
CASE ASSIGNED TO POST REGISTRATION PARALEGAL
23/06/2022
ES7R
TEAS SECTION 7 REQUEST RECEIVED
01/02/2022
R.PR
REGISTERED-PRINCIPAL REGISTER
16/11/2021
NPUB
OFFICIAL GAZETTE PUBLICATION CONFIRMATION E-MAILED
31/08/2021
PUBO
PUBLISHED FOR OPPOSITION
31/08/2021
NONP
NOTIFICATION OF NOTICE OF PUBLICATION E-MAILED
11/08/2021
IUCN
NOTICE OF ALLOWANCE CANCELLED
28/07/2021
ATRQ
ATTORNEY REVIEW/DECISION ON AMENDMENT REQUIRED
09/03/2021
PCBG
PETITION TO DIRECTOR - CHANGE BASIS - GRANTED
09/03/2021
APET
ASSIGNED TO PETITION STAFF
05/03/2021
EXRA
NOTICE OF APPROVAL OF EXTENSION REQUEST E-MAILED
12/02/2021
EX1G
SOU EXTENSION 1 GRANTED
11/02/2021
AITU
CASE ASSIGNED TO INTENT TO USE PARALEGAL
11/02/2021
EXT1
SOU EXTENSION 1 FILED
28/01/2021
EEXT
SOU TEAS EXTENSION RECEIVED
28/01/2021
TPAD
TEAS PETITION TO AMEND BASIS RECEIVED
21/12/2020
NOAM
NOA E-MAILED - SOU REQUIRED FROM APPLICANT
28/07/2020
NPUB
OFFICIAL GAZETTE PUBLICATION CONFIRMATION E-MAILED
02/06/2020
PUBO
PUBLISHED FOR OPPOSITION
02/06/2020
NONP
NOTIFICATION OF NOTICE OF PUBLICATION E-MAILED
13/05/2020
ALIE
ASSIGNED TO LIE
29/04/2020
CNSA
APPROVED FOR PUB - PRINCIPAL REGISTER
23/04/2020
TEME
TEAS/EMAIL CORRESPONDENCE ENTERED
10/04/2020
CRFA
CORRESPONDENCE RECEIVED IN LAW OFFICE
10/04/2020
TROA
TEAS RESPONSE TO OFFICE ACTION RECEIVED
10/04/2020
GNRN
NOTIFICATION OF NON-FINAL ACTION E-MAILED
08/01/2020
GNRT
NON-FINAL ACTION E-MAILED
08/01/2020
CNRT
NON-FINAL ACTION WRITTEN
08/01/2020
TEME
TEAS/EMAIL CORRESPONDENCE ENTERED
19/12/2019
CRFA
CORRESPONDENCE RECEIVED IN LAW OFFICE
19/12/2019
TROA
TEAS RESPONSE TO OFFICE ACTION RECEIVED
19/12/2019
ARAA
ATTORNEY/DOM.REP.REVOKED AND/OR APPOINTED
24/11/2019
REAP
TEAS REVOKE/APP/CHANGE ADDR OF ATTY/DOM REP RECEIVED
24/11/2019
GPRN
NOTIFICATION OF PRIORITY ACTION E-MAILED
26/06/2019
GPRA
PRIORITY ACTION E-MAILED
26/06/2019
CPRA
PRIORITY ACTION WRITTEN
26/06/2019
DOCK
ASSIGNED TO EXAMINER
17/06/2019
NWOS
NEW APPLICATION OFFICE SUPPLIED DATA ENTERED
23/04/2019
NWAP
NEW APPLICATION ENTERED
09/04/2019
Proteção contínua da sua marca
Seja avisado a cada novo depósito que ameace COMMAND-LINE ACCESS TO LIFE ou a sua marca.
Vigilância profissional por 24 meses: monitoramos o USPTO por você e alertamos a tempo de você se opor — antes que o conflito vire prejuízo.